本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mersana Therapeutics Inc.

0.4329
+0.063517.19%
盘前0.4310-0.0019-0.44%08:27 EDT
成交量:329.90万
成交额:133.77万
市值:5,395.29万
市盈率:-0.77
高:0.4423
开:0.3602
低:0.3511
收:0.3694
数据加载中...
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/21

重要事件披露

Form 8-K - Current report
2023/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/31

重要事件披露

Form 8-K - Current report
2023/09/12

重要事件披露

Form 8-K - Current report
2023/09/06

重要事件披露

Form 8-K - Current report
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/07

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals